Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 11.3B | 12.4B | 11.6B | 12.6B |
Cost of revenue | 6.6B | 7.0B | 6.3B | 7.0B |
Gross profit | 4.7B | 5.4B | 5.3B | 5.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.9B | 4.0B | 4.0B | 4.1B |
Other operating expenses | — | — | — | — |
Operating income | 788M | 1.4B | 1.2B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 38M | 8M | 55M | 127M |
Pretax income | 844M | 1.4B | 1.3B | 1.7B |
Tax provision | 50M | 253M | 256M | 226M |
Net income | 794M | 1.2B | 1.1B | 1.5B |
Basic EPS | 0.5 | 0.8 | 0.7 | 1.0 |
Diluted EPS | 0.5 | 0.8 | 0.7 | 1.0 |
Basic average shares | 1.7B | 1.7B | 1.7B | 1.7B |
Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
EBITDA | 1.0B | 1.6B | 1.4B | 1.8B |
Net income from continuing op. | 794M | 1.2B | 1.1B | 1.5B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |